noscript

News and Announcements

Arthritis Relief Plus Completes US FDA Compliance, Receives Government Support & National News Coverage

  • Published August 04, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

ARP has developed and patented a novel technology – Acteev® with its lead product – 4Jointz®, a topical botanical cream addressing a significant unmet market need. It is commercial ready for key international markets.

FY 17 Company Achievements

  • Completed US FDA compliance, securing an OTC topical drug classification for 4Jointz
    Secured Australian Government support in the first cohort at the RocketSpace LandingPad in San Francisco.
  • Awarded new Queensland Government Ignite grant.
  • Completed production of first commercial pilot batch of 4Jointz in the USA.
  • Direct to consumer online sales testing for USA market commenced at www.4jointz.com
  • National and regional broadcast news coverage in Australia.
    investment opportunity now on offer to accelerate USA market growth and support global market partnering activities.

Request Offer

 

ABOUT ARTHRITIS RELIEF PLUS

ARP (USA) Pty Ltd has been granted the rights to commercialize 4JOINTZ® in the USA by Arthritis Relief Plus Ltd, an Australian Biotechnology company, which has developed, patented and successfully completed clinical studies of its unique botanical topical (4JOINTZ®) for pain, stiffness and swelling associated with osteoarthritis and other joint conditions.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now